Skip to main content
. 2002 Jan;53(1):49–57. doi: 10.1046/j.0306-5251.2001.01529.x

Table 2.

Clinical progress and outcome. Values are expressed as †median (range).

Diazepam i.v. (n = 16) Diazepam p.r. (n = 9)
Admission Blantyre coma score† 1 0 0 (0 0 0–2 2 1) 0 1 0 (0 0 0–2 1 0)
4 h Blantyre Coma Score (BCS)† 1 1 0 (0 0 0–2 2 1) 2 1 0 (0 0 0–2 2 1)
Decline in BCS at 4 h 4 2
Episode of hypoglycaemia 2 3
Transfusion 3 2
Convulsions before admission† 3 (0–99) 1 (0–99)
Prolonged convulsion (> 30 min) 6 6
Convulsions after admission† 1 (0–28) 3 (0–44)
Convulsion terminated with first DZ dose 16 4
Convulsions after treatment with first DZ† 1 (1–28) 3 (3–43)
2nd dose of DZ or PAR 9 7
3rd line treatment (PHEN) 6 6
Convulsion >30 min after treatment 6 3
Deaths 0 1
Gross neurological sequelae on discharge 2 1